TU Dresden


β-cell biology and regeneration - Nikolay Ninov

The pancreatic β-cells are the key metabolic sensors and effectors for insulin release, which is the only hormone known to lower blood glucose concentrations. Type 1 diabetes mellitus is an autoimmune disease characterized by the destruction of beta-cells in the pancreatic islets, leading to insulin deficiency and hyperglycemia.  In contrast, type 2 diabetes commences with insulin resistance followed by beta cell loss and hyperglycemia.  Restoring functional β-cell mass is recognized as a promising therapeutic avenue towards normalizing glycemic control in both type 1 and 2 diabetics.  Thus, our research goal is to understand the molecular and cellular events required for pancreatic β-cell regeneration, and apply this knowledge towards the development of cell replacement therapies for diabetes.

Previous and current research

The goal of our group is to identify new signaling pathways and drugs that enhance endogenous beta-cell regeneration. Using a set of novel transgenic reporter zebrafish lines, which monitor beta-cell proliferation in the living animal, we have performed the first in vivo high-content chemical screen for inducers of beta-cell proliferation, which identified FDA-approved drugs and natural products that expand beta-cell mass. more

Future projects and goals

  • High content in vivo drug screens for inducers of pancreatic β-cell differentiation and replication.
  • Metabolic control of β-cell proliferation.
  • Notch signaling in pancreatic stem cell differentiation and renewal.
  • Novel (drug) targets for pancreatic stem cell activation and differentiation into β-cells.

Group leader

Selected publications

Salem V*., Delgadillo L*, Suba K., Georgiadou1 E., Mousavy NG., Akhtar N., Martin-Alonso A., Gaboriau D., Rothery S., Stylianides T., Carrat G., Pullen T., Pal Singh T., Hodson D., Leclerc I., Shapiro J., Marchetti P., Linford B.,, Distaso W., Ninov N** and Rutter GA**.  Leader β cells coordinate Ca2+ dynamics across pancreatic islets in vivo.  Nature Metabolism, (2019) (accepted).
*joint first authors; ** co-corresponding authors

Delgadillo L., Tsakmaki A., Akhtar N., Franklin Z., Konantz J., Bewick GA., and Ninov N.  Modelling pancreatic β-cell inflammation in zebrafish identifies the natural product wedelolactone for human islet protection.  Disease Models & Mechanisms (2019) 12, doi:10.1242/dmm.036004    

Janjuha S*., Singh SP*., Tsakmaki A., Gharavy NM., Murawala P., Konantz J., Birke S., Hodson D., Rutter G., Bewick G., and Ninov N. Age-related islet inflammation marks the proliferative decline of pancreatic beta-cells in zebrafish. eLIFE (2018), doi: 10.7554/eLife.32965

Spanjaard B.; Hu B.; Mitic N.; Olivares-Chauvet P.; Janjuha S.; Ninov N.; Junker J.P.; Simultaneous lineage tracing and cell type identification using CRISPR/Cas9 induced genetic scars Nature Biotechnology (2018), doi: 10.1038/nbt.4124

Singh SP, Janjuha S, Hartmann T, Kayısoglu O, Konantz J, Birke S, Murawala P, Alfar EA, Murata K, Eugster A, Tsuji N, Morrissey E, Brand M, and Ninov N. Different developmental histories of beta-cells generate functional and proliferative heterogeneity during islet growth. Nature Communications (2017). DOI : 10.1038/s41467-017-00461-3.


Group Leader

Dr. Nikolay Ninov

Assistant to Group Leader

Silvia Palme

Phone: +49 (0)351 458 82104